SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-000216
Filing Date
2021-01-05
Accepted
2021-01-05 08:30:30
Documents
52
Period of Report
2021-01-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20210105.htm   iXBRL 8-K 46182
2 EX-99.1 agle-ex991_28.htm EX-99.1 43340
3 GRAPHIC slide-itvqpbgot00.jpg GRAPHIC 49541
4 GRAPHIC slide-fnqgb5bcag0.jpg GRAPHIC 18143
5 GRAPHIC slide-asxshu5kytr.jpg GRAPHIC 54236
6 GRAPHIC slide-odvqqszzgje.jpg GRAPHIC 57838
7 GRAPHIC slide-vrskm0xtzve.jpg GRAPHIC 60918
8 GRAPHIC slide-yfsltav0keh.jpg GRAPHIC 51532
9 GRAPHIC slide-f4bf5zatzgy.jpg GRAPHIC 66190
10 GRAPHIC slide-ppnyl0thy0a.jpg GRAPHIC 18027
11 GRAPHIC slide-n1heddvcyzm.jpg GRAPHIC 51316
12 GRAPHIC slide-u5tqnl1yw4p.jpg GRAPHIC 19960
13 GRAPHIC slide-mrfata1voyn.jpg GRAPHIC 65238
14 GRAPHIC slide-xy1bpb4qhnd.jpg GRAPHIC 29540
15 GRAPHIC slide-tzr1dqhy3xe.jpg GRAPHIC 76167
16 GRAPHIC slide-qlff241vrgu.jpg GRAPHIC 63799
17 GRAPHIC slide-1pcefi1uo3x.jpg GRAPHIC 50213
18 GRAPHIC slide-qv13m5uc1uq.jpg GRAPHIC 53715
19 GRAPHIC slide-tydxpvwfflf.jpg GRAPHIC 51810
20 GRAPHIC slide-z3kr0rv35a1.jpg GRAPHIC 16358
21 GRAPHIC slide-tci0rugcc3f.jpg GRAPHIC 54248
22 GRAPHIC slide-tcaglfdszt0.jpg GRAPHIC 66008
23 GRAPHIC slide-wucchlaw1bf.jpg GRAPHIC 52042
24 GRAPHIC slide-q4i1kdvi5vc.jpg GRAPHIC 111629
25 GRAPHIC slide-dalx4xzms3r.jpg GRAPHIC 43045
26 GRAPHIC slide-ehk4qtfqzoq.jpg GRAPHIC 61204
27 GRAPHIC slide-fio5gusdwz2.jpg GRAPHIC 62125
28 GRAPHIC slide-1yypxclgmgv.jpg GRAPHIC 49472
29 GRAPHIC slide-pqphjsbwghc.jpg GRAPHIC 52751
30 GRAPHIC slide-mqldlzl2w3p.jpg GRAPHIC 43354
31 GRAPHIC slide-zxevle3hpuq.jpg GRAPHIC 61325
32 GRAPHIC slide-05wwpql4r41.jpg GRAPHIC 56760
33 GRAPHIC slide-sqat5rkkcwx.jpg GRAPHIC 52978
34 GRAPHIC slide-mtt3tyrokjd.jpg GRAPHIC 51293
35 GRAPHIC slide-rdidxmeznvv.jpg GRAPHIC 56256
36 GRAPHIC slide-lfjrkcv4egx.jpg GRAPHIC 66475
37 GRAPHIC slide-aqgqte0tgsm.jpg GRAPHIC 61202
38 GRAPHIC slide-bnapa5kehdr.jpg GRAPHIC 20506
39 GRAPHIC slide-xpmox0sppsj.jpg GRAPHIC 55515
40 GRAPHIC slide-bh5rfep3kwc.jpg GRAPHIC 56542
41 GRAPHIC slide-zipape5dlnc.jpg GRAPHIC 34020
  Complete submission text file 0001564590-21-000216.txt   3034139

Data Files

Seq Description Document Type Size
42 XBRL TAXONOMY EXTENSION SCHEMA agle-20210105.xsd EX-101.SCH 5764
43 XBRL TAXONOMY EXTENSION LABEL LINKBASE agle-20210105_lab.xml EX-101.LAB 20227
44 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agle-20210105_pre.xml EX-101.PRE 12075
45 EXTRACTED XBRL INSTANCE DOCUMENT agle-8k_20210105_htm.xml XML 3689
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 21503997
SIC: 2834 Pharmaceutical Preparations